ARCHIVES

CT Scanning Use, Costs, Controls Debated By NCAB

This article is from The Cancer Letter archive.

Vol. 03 No. 40 | October 7, 1977

Download PDF Visit The Full Archive

Related Articles

In Brief: Breast Cancer coalition Plan Rally, Conference; FDA Seeks Information On Unlabeled Drug Uses

April 30, 1993

NCAB To Monitor Virus Program; NCI Answers Zinder Report Criticisms

June 28, 1974

More Clinical Trials Money Top Priority, DeVita Says; Drug Discovery Groups RFA Gets 12 Applications

February 24, 1984

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

ACS Plans 7 Hearings Around U.S. On cancer In The Disadvantaged

April 7, 1989